Canada· CA-DIN-02330253

NATURALYTE H-232

A hemodialytics, concentrates product containing potassium chloride + acetic acid + dextrose + sodium chloride, registered in Canada by FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP, LLC. The same ATC class is registered in 2 of our 19 countries.

ATC B05ZA

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedNATURALYTE H-232ATCB05ZAREGISTER NO.CA-DIN-02330253PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Potassium chloride + acetic acid + dextrose + sodium chloride is registered in 2 of 19 countries.

Countries holding a registration under ATC B05ZA (hemodialytics, concentrates), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 1 of them publish a price we can compare per daily dose

Potassium chloride + acetic acid + dextrose + sodium chloride · ATC B05ZA

2 / 19 countries

  • Canada
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
POTASSIUM CHLORIDE + ACETIC ACID + DEXTROSE + SODIUM CHLORIDE
Manufacturer
FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP, LLC
Country
Canada (CA)
ATC code
B05ZA
ATC class
Hemodialytics, concentrates
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ef8bcf3b-53b5-45a4-bc75-5367dc16bd64
GET /v1/drugs/ef8bcf3b-53b5-45a4-bc75-5367dc16bd64?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02330253",
  "form": "SOLUTION",
  "class": "Human",
  "routes": [
    "HAEMODIALYSIS"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "B05ZA",
  "schedule": [
    "Ethical"
  ],
  "drug_code": "81601",
  "strengths": [
    "6.71 G",
    "10.8 G",
    "49.49 G",
    "263 G",
    "8.27 G",
    "3.43 G"
  ],
  "ahfs_class": null,
  "substances": [
    "POTASSIUM CHLORIDE",
    "ACETIC ACID",
    "DEXTROSE",
    "SODIUM CHLORIDE",
    "CALCIUM CHLORIDE",
    "MAGNESIUM CHLORIDE"
  ],
  "product_categorization": null
}

See everything about potassium chloride + acetic acid + dextrose + sodium chloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.